Margenza 250 mg in 10 mL Injection
RxNorm 2474033
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 2474033 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Margenza 250 mg in 10 mL Injection.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SYPrescribable
Synonym (SY):
10 mL Margenza 25 mg/ML Injection
(Atom ID: 12531970)
SBDPrescribable
Semantic Branded Drug (SBD):
10 mL margetuximab-cmkb 25 mg/ML Injection [Margenza]
(Atom ID: 12531968)
PSNPrescribable
Prescribable Name (PSN):
Margenza 250 mg in 10 mL Injection
(Atom ID: 12531969)
SYPrescribable
Synonym (SY):
Margenza 250 mg per 10 mL Injection
(Atom ID: 12531971)
Patient Education
Margetuximab-cmkb Injection
Margetuximab-cmkb is used along with chemotherapy to treat a certain type of breast cancer (HER-2 positive) that has spread to other parts of the body after treatment with at least two other chemotherapy medications. Margetuximab-cmkb is in a class of medications called monoclonal antibodies. It works by stopping the growth of cancer cells.
[Learn More]
* Please review the disclaimer below.